All stock lists
Galera Therapeutics, Inc. (OTC:GRTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
17.15+1.53 (+9.80%)
Insider Score
––Not scored
GRTX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
GRTX analyst forecast
Best analysts covering GRTX
No firm covering GRTX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
GRTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Citigroup | Neutral | — | — | Reiterated | 2023-08-29 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2023-08-16 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2023-08-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-07-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-22 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-02-21 |
| — | B of A Securities | Buy | — | — | Upgraded | 2023-02-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-02-16 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2022-05-27 |
| — | Citigroup | Buy | — | — | Reiterated | 2021-12-20 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2021-12-15 |
| — | BTIG | Buy | — | — | Upgraded | 2021-12-15 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2021-10-20 |
| — | BTIG | Neutral | — | — | Downgraded | 2021-10-19 |
| — | Credit Suisse | Outperform | — | — | Upgraded | 2020-12-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2020-12-07 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2020-11-11 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2020-07-29 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2019-12-02 |
| — | Citi | Buy | — | — | Reiterated | 2019-12-02 |
| — | BTIG Research | Buy | — | — | Reiterated | 2019-12-02 |
| — | Bank of America | Buy | — | — | Reiterated | 2019-12-02 |
GRTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-08-13 | 165.45 | -14.00 | $50.0M | $0 |
| 2025-11-13 | -58.00 | -0.01 | $0 | $0 |
| 2026-03-19 | -60.00 | 0.66 | $0 | $0 |
| 2026-05-14 | -0.83 | -0.01 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.